Debuigne, A., Berger, M., Toussaint, F., Ben Djemaa, S., Jérôme, C., Lechanteur, A., Mottet, D., & Piel, G. (07 May 2025). Lipid-poly(N-vinylamide) conjugates as PEG alternatives towards safer and efficient siRNA delivery systems [Paper presentation]. Advanced Polymers via Macromolecular Engineering [APME], Catania, Italy.  Peer reviewed |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Leblond Chain, J., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (December 2024). Development of lipid nanoparticles based on PEG alternatives for efficient siRNA delivery [Paper presentation]. 1Oth annual meeting of SFNano, Toulouse, France. Peer reviewed |
Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (07 November 2024). Polymer derivatives and their use as lipid nanoparticle modifiers. |
Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (06 November 2024). Polymer derivatives and their use as lipid nanoparticle modifiers. |
Debuigne, A., Berger, M., Toussaint, F., Ben Djemaa, S., Jérôme, C., Lechanteur, A., Mottet, D., & Piel, G. (24 April 2024). Poly(N-vinyl amide)-lipid conjugates as poly(ethylene glycol) alternatives for the modification of lipid-based nanocarriers [Paper presentation]. Materials Research Society (MRS) Spring Meeting, Seattle, United States. Peer reviewed |
Berger, M., Toussaint, F., Ben Djemaa, S., Maquoi, E., Pendeville-Samain, H., Evrard, B., Jérôme, C., Leblond Chain, J., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (March 2024). Innovative siRNA-based lipid nanoparticles decorated with PEG alternatives (PNVP and PNMVA) to circumvent dilemma and immunogenicity [Paper presentation]. 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical (PBP) Technology, Vienne, Austria. Peer reviewed |
Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (2023). Polymer Derivative and their use as lipid nanoparticle modifiers”. |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (30 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP World Meeting), Rotterdam, Netherlands. |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (09 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 2022 Meeting of the Germany and BeNeLux & France Local Chapters of the Controlled Release Society in Aachen, Aachen, Germany. |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Debuigne, A., Mottet, D., Lechanteur, A., & Piel, G. (May 2021). Impact of amphiphilic N-vinyl pyrrolidone-based polymers used as PEG alternative on lipoplexes physico-chemical properties, cytotoxicity and gene delivery [Poster presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium. |
  | Bruniaux, J., Allard-Vannier, E., Aubrey, N., Lakhrif, Z., Ben Djemaa, S., Eljack, S., Marchais, H., Hervé-Aubert, K., Chourpa, I., & David, S. (05 October 2019). Magnetic nanocarriers for the specific delivery of siRNA: Contribution of breast cancer cells active targeting for down-regulation efficiency. International Journal of Pharmaceutics, 569, 118572. doi:10.1016/j.ijpharm.2019.118572 Peer Reviewed verified by ORBi |
 | Ben Djemaa, S., Munnier, E., Chourpa, I., Allard-Vannier, E., & David, S. (15 August 2019). Versatile electrostatically assembled polymeric siRNA nanovectors: Can they overcome the limits of siRNA tumor delivery? International Journal of Pharmaceutics, 567, 118432. doi:10.1016/j.ijpharm.2019.06.023 Peer Reviewed verified by ORBi |
 | Ben Djemaa, S., Hervé-Aubert, K., Lajoie, L., Falanga, A., Galdiero, S., Nedellec, S., Soucé, M., Munnier, E., Chourpa, I., David, S., & Allard-Vannier, E. (2019). gH625 Cell-Penetrating Peptide Promotes the Endosomal Escape of Nanovectorized siRNA in a Triple-Negative Breast Cancer Cell Line. Biomacromolecules, 20 (8), 3076-3086. doi:10.1021/acs.biomac.9b00637 Peer Reviewed verified by ORBi |
 | Ben Djemaa, S., David, S., Hervé-Aubert, K., Falanga, A., Galdiero, S., Allard-Vannier, E., Chourpa, I., & Munnier, E. (October 2018). Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis. European Journal of Pharmaceutics and Biopharmaceutics, 131, 99-108. doi:10.1016/j.ejpb.2018.07.024 Peer Reviewed verified by ORBi |
 | Ben Djemaa, S., Pacaud, M., Herv -Aubert, K., David, S. P., Allard-Vannier, E., Munnier, E., Ignatova, A., Fahmi, A., Feofanov, A., & Chourpa, I. (August 2018). Fluorescence Microscopy as a Tool for Nanomedicine-Cell Interactions Study: Input of Particle Design and of Analytical Strategy. Microscopy and Microanalysis, 24 (S1), 1316 - 1317. doi:10.1017/S1431927618007067 Peer Reviewed verified by ORBi |
 | Bruniaux, J., Ben Djemaa, S., Hervé-Aubert, K., Marchais, H., Chourpa, I., & David, S. (05 November 2017). Stealth magnetic nanocarriers of siRNA as platform for breast cancer theranostics. International Journal of Pharmaceutics, 532 (2), 660-668. doi:10.1016/j.ijpharm.2017.05.022 Peer Reviewed verified by ORBi |
 | Abdelrahman, M., Douziech Eyrolles, L., Alkarib, S. Y., Hervé-Aubert, K., Ben Djemaa, S., Marchais, H., Chourpa, I., & David, S. (30 August 2017). siRNA delivery system based on magnetic nanovectors: Characterization and stability evaluation. European Journal of Pharmaceutical Sciences, 106, 287-293. doi:10.1016/j.ejps.2017.05.062 Peer Reviewed verified by ORBi |
